Financial Contrast: Avid Bioservices (NASDAQ:CDMO) and Ascentage Pharma Group International (NASDAQ:AAPG)

Avid Bioservices (NASDAQ:CDMO) and Ascentage Pharma Group International (NASDAQ:AAPG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Avid Bioservices and Ascentage Pharma Group International, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avid Bioservices	0	4	0	0	2.00
Ascentage Pharma Group International	0	0	0	0	0.00

Avid Bioservices presently has a consensus price target of $12.25, indicating a potential downside of 1.96%. Given Avid Bioservices’ stronger consensus rating and higher possible upside, equities analysts plainly believe Avid Bioservices is more favorable than Ascentage Pharma Group International.

Institutional and Insider Ownership

97.2% of Avid Bioservices shares are owned by institutional investors. 3.1% of Avid Bioservices shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Avid Bioservices and Ascentage Pharma Group International”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avid Bioservices	$139.91 million	5.71	-$140.75 million	($2.39)	-5.23
Ascentage Pharma Group International	$903.03 million	2.02	N/A	N/A	N/A

Ascentage Pharma Group International has higher revenue and earnings than Avid Bioservices.

Profitability

This table compares Avid Bioservices and Ascentage Pharma Group International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avid Bioservices	-101.07%	-33.18%	-8.45%
Ascentage Pharma Group International	N/A	N/A	N/A

Summary

Avid Bioservices beats Ascentage Pharma Group International on 5 of the 9 factors compared between the two stocks.

About Avid Bioservices

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

About Ascentage Pharma Group International

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.